The Val158Met polymorphism of the catechol-O-methyltransferase gene is not associated with the risk of sporadic or latent prostate cancer in Japanese men

International Journal of Urology

Volumn 14, Issue 9, 2007, Pages 800-804

  Suzuki, Motofumi ^a   Kurosaki, Takayuki ^a   Arai, Tomio ^b   Sawabe, Motoji ^b   Hosoi, Takayuki ^c   Kitamura, Tadaichi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b Tokyo Metropolitan Institute of Gerontology   (Japan)

^c NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

Author keywords

Catechin; Chemoprevention; Latent prostate cancer; Sporadic prostate cancer; Val158Met polymorphism of COMT

Indexed keywords

CATECHOL METHYLTRANSFERASE;

AGED; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CATALYSIS; CONTROLLED STUDY; ENZYME ACTIVITY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; METHYLATION; PRIORITY JOURNAL; PROSTATE CANCER; SINGLE NUCLEOTIDE POLYMORPHISM;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; CATECHOL O-METHYLTRANSFERASE; HUMANS; JAPAN; MALE; METHIONINE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATIC NEOPLASMS; RISK FACTORS; VALINE;

EID: 34548182753     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2007.01822.x     Document Type: Article

References (37)

1. Edwards BK, Brown ML, Wingo PA et al. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J. Natl. Cancer Inst. 2005 97:1407 27.
2. Sim HG, Cheng CW. Changing demography of prostate cancer in Asia. Eur. J. Cancer 2005 41:834 45.
3. Grönberg H. Prostate cancer epidemiology. Lancet 2003 361:859 64.
4. Quinn M, Babb P. Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part I: International comparisons. BJU Int. 2002 90:162 73.
5. Shimizu H, Ross RK, Bernstein L, Yatani R, Henderson BE, Mack TM. Cancers of the prostate and breast among Japanese and white immigrants in Los Angels County. Br. J. Cancer 1991 63:963 6.
6. Cook LS, Goldoft M, Schwartz SM, Weiss NS. Incidence of adenocarcinoma of the prostate in Asian immigrants to the United States and their descendants. J. Urol. 1999 161:152 5.
7. Marks LS, Kojima M, Demarzo A et al. Prostate cancer in native Japanese and Japanese-American men: Effects of dietary differences on prostatic tissue. Urology 2004 64:765 71.
8. Suzuki K, Nakazato H, Matsui H et al. Genetic polymorphisms of estrogen receptor alpha, CYP19, catechol-O-methyltransferase are associated with familial prostate carcinoma risk in a Japanese population. Cancer 2003 98:1411 16.
9. Zhu BT, Conney AH. Functional role of estrogen metabolism in target cells: Review and perspectives. Carcinogenesis 1998 19:1 27.
10. Cavalieri EL, Stack DE, Devanesan PD et al. Molecular origin of cancer: Catechol estrogen-3,4-quinones as endogenous tumor initiators. Proc. Natl. Acad. Sci. USA 1997 94:10937 42.
11. Cavalieri EL, Devanesan P, Bosland MC, Badawi AF, Rogan EG. Catechol estrogen metabolites and conjugates in different regions of the prostate of Noble rats treated with 4-hydroxyestradiol: Implications for estrogen-induced initiation of prostate cancer. Carcinogenesis 2002 23:329 33.
12. Lakhani NJ, Sarkar MA, Venitz J, Figg WD. 2-Methoxyestradiol, a promising anticancer agent. Pharmacotherapy 2003 23:165 72.
13. Lachman HM, Papolos DF, Saito T, Yu YM, Szumlanski CL, Weinshilboum RM. Human catechol-O-methyltransferase pharmacogenetics: Description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 1996 6:243 50.
14. Chen J, Lipska BK, Halim N et al. Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): Effects on mRNA, protein, and enzyme activity in postmortem human brain. Am. J. Hum. Genet. 2004 75:807 21.
15. Tanaka Y, Sasaki M, Shiina H et al. Catechol-O-methyltransferase gene polymorphisms in benign prostatic hyperplasia and sporadic prostate cancer. Cancer Epidemiol. Biomarkers Prev. 2006 15:238 44.
16. Suzuki M, Mamun MR, Hara K et al. The Val158Met polymorphism of the catechol-O-methyltransferase gene is associated with the PSA-progression-free survival in prostate cancer patients treated with estramustine phosphate. Eur. Urol. 2005 48:752 9.
17. Sawabe M, Arai T, Kasahara I et al. Developments of geriatric autopsy database and Internet-based database of Japanese single nucleotide polymorphisms for geriatric research (JG-SNP). Mech. Ageing Dev. 2004 125:547 52.
18. Hirakawa M, Tanaka T, Hashimoto Y, Kuroda M, Takagi T, Nakamura Y. JSNP: A database of common gene variations in the Japanese population. Nucleic Acids Res. 2002 30:158 62.
19. Haga H, Yamada R, Ohnishi Y, Nakamura Y, Tanaka T. Gene-based SNP discovery as part of the Japansese Millennium Genome Project: Identification of 190 5 62 genetic variations in the human genome. Single-nucleotide polymorphism. J. Hum. Genet. 2002 47:605 10.
20. Zhu BT, Patel UK, Cai MX, Conney AH. O-Methylation of tea polyphenols catalyzed by human placental cytosolic catechol-O-methyltransferase. Drug Metab. Dispos. 2000 28:1024 30.
21. Cao Y, Cao R. Angiogenesis inhibited by drinking tea. Nature 1999 398:381.
22. Gupta S, Hastak K, Ahmad N, Lewin JS, Mukhtar H. Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols. Proc. Natl. Acad. Sci. USA 2001 98:10350 5.
23. Caporali A, Davalli P, Astancolle S et al. The chemopreventive action of catechins in the TRAMP mouse model of prostate carcinogenesis is accompanied by clusterin over-expression. Carcinogenesis 2004 25:2217 24.
24. Bettuzzi S, Brausi M, Rizzi F, Castagnetti G, Peracchia G, Corti A. Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: A preliminary report from a one-year proof-of-principle study. Cancer Res. 2006 66:1234 40.
25. Palmatier MA, Kang AM, Kidd KK. Global variation in the frequencies of functionally different catechol-O-methyltransferase alleles. Biol. Psychiatry 1999 46:557 67.
26. Lavigne JA, Helzlsouer KJ, Huang HY et al. An association between the allele coding for a low activity variant of catechol-O-methyltransferase and the risk for breast cancer. Cancer Res. 1997 57:5493 7.
27. Thompson PA, Shields PG, Freudenheim JL et al. Genetic polymorphisms in catechol-O-methyltransferase, menopausal status, and breast cancer risk. Cancer Res. 1998 58:2107 10.
28. Millikan RC, Pittman GS, Tse CK et al. Catechol-O-methyltransferase and breast cancer risk. Carcinogenesis 1998 19:1943 7.
29. Mitrunen K, Jourenkova N, Kataja V et al. Polymorphic catechol-O-methyltransferase gene and breast cancer risk. Cancer Epidemiol. Biomarkers Prev. 2001 10:635 40.
30. Goodman JE, Lavigne JA, Wu K et al. COMT genotype, micronutrients in the folate metabolic pathway and breast cancer risk. Carcinogenesis 2001 22:1661 5.
31. Huang CS, Chern HD, Chang KJ, Cheng CW, Hsu SM, Shen CY. Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: A multigenic study on cancer susceptibility. Cancer Res. 1999 59:4870 5.
32. Yim DS, Parkb SK, Yoo KY et al. Relationship between the Val158Met polymorphism of catechol O-methyl transferase and breast cancer. Pharmacogenetics 2001 11:279 86.
33. Hamajima N, Matsuo K, Tajima K et al. Limited association between a catechol-O-methyltransferase (COMT) polymorphism and breast cancer risk in Japan. Int. J. Clin. Oncol. 2001 6:13 18.
34. Bergman-Jungestrom M, Wingren S. Catechol-O-methyltransferase (COMT) gene polymorphism and breast cancer risk in young women. Br. J. Cancer 2001 85:859 62.
35. Kocabas NA, Sardas S, Cholerton S, Daly AK, Karakaya AE. Cytochrome P450 CYP1B1 and catechol-O-methyltransferase (COMT) genetic polymorphisms and breast cancer susceptibility in a Turkish population. Arch. Toxicol. 2002 76:643 9.
36. Wedren S, Rudqvist TR, Granath F et al. Catechol-O-methyltransferase gene polymorphism and post-menopausal breast cancer risk. Carcinogenesis 2003 24:681 7.
37. Wu AH, Tseng CC, Van Den Berg D, Yu MC. Tea intake, COMT genotype, and breast cancer in Asian-American women. Cancer Res. 2003 63:7526 9.